I understand what you are going through.
Perhaps the PET scan result showed progressive disease, thus the decision to shift the management to chemotherapy.
The survival depends on how your mother responds to her new treatment. If she is responsive, her survival will be prolonged.
It would be best to discuss treatment options to your mother's oncologist as there are newer chemotherapy regimens available involving targeted therapy.
Thanks Dennis, for your prompt response, Doctors have put her now on AROMASIN-25 (Pfizer) and ZOMETA, instead of XELODA for the next three months.
They have chosen this combination instead of conventional chemo at the hospital.
What might have been the reason and what this AROMASIN oral pills (one daily) will do
instead of 5 tabs daily of XELODA, which she has been taking for the last five months.
Aromasin is an oral hormonal therapy used in breast cancer treatment.
Capecitabine (Xeloda) is a form of oral chemotherapy used in breast cancer and also in other cancer types.
Zometa is a bisphosphonate used for bone metastasis to relieve bone pains as well as control the bone metastasis.
From what you posted, my understanding is that your mother was previously on Xeloda and her regimen was shifted to Aromasin?
The reason for shifting the regimen could be a progressive disease while on Xeloda.